Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.17 USD
Change Today +0.13 / 1.85%
Volume 303.5K
XNPT On Other Exchanges
As of 4:30 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William G. Harris

Chief Financial Officer and Senior Vice President of Finance, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. William G. Harris, also known as Bill, has been the Chief Financial Officer and Senior Vice President of Finance of Xenoport, Inc. since November 2001 and serves as its Principal Accounting Officer. From July 1996 to January 2000, Mr. Harris served as the Chief Financial Officer and Vice President of Coulter Pharmaceutical. He served as Senior Vice President of Coulter Pharmaceutical since February 2000. From July 1992 to July 1996, he served as a Director of Finance ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Former Director and Chairman of Audit Committee
Independent Director, Chairman of Audit Committee and Member of Compensation Committee


University of California - San Diego
Santa Clara University Graduate School of Business

Other Affiliations*

Annual Compensation*

Total Annual Compensation$369,195

Stock Options*

Restricted Stock Awards$176,000
All Other Compensation$5,874
Exercised Options25,000
Exercised Options Value$129,050
Exercisable Options245,143
Exercisable Options Value$71,100
Unexercisable Options64,689
Unexercisable Options Value$22,031
Total Value of Options$222,181
Total Number of Options334,832

Total Compensation*

Total Annual Cash Compensation$375,069
Total Short Term Compensation$369,195
Other Long Term Compensation$181,874
Total Calculated Compensation$811,966
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $7.17 USD +0.13


Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at